The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. - de Leon,J.; Susce,MT.; Pan,RM.; Fairchild,M.; Koch,W.; Wedlund,PJ. (J Clin Psychiatry, 2005)